Drug Trial Radar · NCT05093634
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
296
Actual
Start
Apr 26, 2022
Primary completion
Dec 19, 2025
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Rhythm Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 26, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The protocol describes a randomized, double-blind, placebo-controlled trial with independent sub-studies of setmelanotide in participants with obesity and at least one of the specific gene variants in the Melanocortin-4 Receptor pathway: * Pro-opiomelanocortin (POMC) or proprotein convertase subtilisin/kexin type 1 (PCSK1; Sub-study 035a) * Leptin receptor (LEPR; Sub-study 035b) * Nuclear receptor coactivator 1 (NCOA1; steroid receptor coactivator 1 \[SCR1\]; Sub-study 035c) * Steroid receptor coactivator-1 homology 2 B adapter protein 1 (SH2B1; Sub-study 035d) The objectives and endpoints are identical for these sub-studies.
Conditions
- Obesity
- Genetic Obesity
Interventions
SetmelanotideDrug
Subcutaneous Injection
PlaceboDrug
Subcutaneous Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Period: Percent Change From Baseline in Body Mass Index (BMI)Time frame: Baseline, Week 52
Locations
66 sites in 10 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
HonorHealth Bariatric Center
Scottsdale, Arizona
Children's Hospital Los Angeles
Los Angeles, California
Children's Hospital Colorado
Aurora, Colorado
Yale Center for Clinical Investigation
New Haven, Connecticut
Advent Health
Altamonte Springs, Florida
University of Florida
Gainesville, Florida
InQuest Medical Research
Suwanee, Georgia
UMASS Memorial Medical Center
Worcester, Massachusetts
University of Michigan
Ann Arbor, Michigan
Metro Detroit Endocrinology Center
Dearborn, Michigan
Mayo Clinic
Rochester, Minnesota
Mississippi Center for Advanced Medicine
Madison, Mississippi
St. Luke's Hospital
Chesterfield, Missouri
Children's Mercy
Kansas City, Missouri
Washington University in St. Louis
St Louis, Missouri
University of Buffalo
Buffalo, New York
Metropolitan Hospital Center
New York, New York
Mount Sinai Hospital
New York, New York
Columbia University
New York, New York
Ten's Medical Center - Pediatric Endocrinology Clinic
Staten Island, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Oregon Health & Science University
Portland, Oregon
Geisinger Clinic
Danville, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
UPMC Montefiore
Pittsburgh, Pennsylvania
Vanderbilt University School of Medicine
Nashville, Tennessee
Texas Tech
Amarillo, Texas
Texas Children's Hospital
Houston, Texas
Biopharma Informatic
Houston, Texas
Rio Grande Valley Endocrine Center
McAllen, Texas
Endocrine Associates of Dallas and Plano
Plano, Texas
MultiCare Health System Institute for Research and Innovation
Tacoma, Washington
West Virginia University
Morgantown, West Virginia
Marshfield Clinic Research Foundation, a Division of Marshfield Clinic, Inc
Marshfield, Wisconsin
University of Alberta - Alberta Diabetes Institute (ADI)
Edmonton, Alberta, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
GH Est Hopital Femme Mere Enfant
Lyon, France
Hu Pitie Salpetriere Aphp
Paris, France
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.